Victory Capital Management Inc. reduced its stake in RTI Surgical, Inc. (NASDAQ:RTIX) by 16.5% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 218,274 shares of the medical equipment provider’s stock after selling 43,132 shares during the period. Victory Capital Management Inc. owned 0.37% of RTI Surgical worth $873,000 at the end of the most recent reporting period.
Other large investors also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp boosted its stake in RTI Surgical by 3.5% in the first quarter. Bank of New York Mellon Corp now owns 255,656 shares of the medical equipment provider’s stock valued at $1,022,000 after buying an additional 8,679 shares in the last quarter. Ameriprise Financial Inc. boosted its position in shares of RTI Surgical by 29.5% in the first quarter. Ameriprise Financial Inc. now owns 44,807 shares of the medical equipment provider’s stock worth $180,000 after buying an additional 10,215 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of RTI Surgical by 0.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,825,098 shares of the medical equipment provider’s stock worth $12,432,000 after buying an additional 10,573 shares during the period. TFS Capital LLC boosted its position in shares of RTI Surgical by 42.6% in the first quarter. TFS Capital LLC now owns 42,132 shares of the medical equipment provider’s stock worth $169,000 after buying an additional 12,587 shares during the period. Finally, Nine Chapters Capital Management LLC boosted its position in shares of RTI Surgical by 75.9% in the first quarter. Nine Chapters Capital Management LLC now owns 35,000 shares of the medical equipment provider’s stock worth $140,000 after buying an additional 15,100 shares during the period. 68.74% of the stock is currently owned by institutional investors and hedge funds.
RTI Surgical, Inc. (RTIX) opened at 5.60 on Friday. The firm’s 50-day moving average is $4.97 and its 200-day moving average is $3.91. The firm’s market capitalization is $325.51 million. RTI Surgical, Inc. has a 12 month low of $2.50 and a 12 month high of $5.75.
RTI Surgical (NASDAQ:RTIX) last announced its earnings results on Thursday, April 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter. The company had revenue of $69.90 million for the quarter, compared to the consensus estimate of $67.68 million. RTI Surgical had a positive return on equity of 1.34% and a negative net margin of 6.85%. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.03 EPS. On average, equities research analysts expect that RTI Surgical, Inc. will post $0.08 EPS for the current year.
RTIX has been the topic of a number of recent research reports. TheStreet raised shares of RTI Surgical from a “d+” rating to a “c-” rating in a research report on Friday, May 5th. ValuEngine raised shares of RTI Surgical from a “sell” rating to a “hold” rating in a research report on Friday, June 2nd. Finally, Zacks Investment Research raised shares of RTI Surgical from a “sell” rating to a “hold” rating in a research report on Thursday, May 11th.
In related news, CEO Camille Farhat bought 61,693 shares of the firm’s stock in a transaction on Thursday, May 18th. The stock was purchased at an average price of $4.65 per share, with a total value of $286,872.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Kevin D. Brandt bought 33,130 shares of the firm’s stock in a transaction on Wednesday, May 3rd. The shares were bought at an average cost of $4.52 per share, with a total value of $149,747.60. Following the transaction, the executive vice president now directly owns 126,215 shares of the company’s stock, valued at $570,491.80. The disclosure for this purchase can be found here. Insiders have acquired 112,023 shares of company stock valued at $514,421 in the last ninety days. Company insiders own 4.90% of the company’s stock.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.